NYSE:SER | Cash Flow Statement | Serina Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$6.36M
2026-03-31-$6.9M$0.00-$4.57M$25,000.00-$25,000.00$26.06M
2025-12-31-$3.34M-$6.03M$0.00$0.00$481,000.00
2025-09-30-$4.59M
2025-06-30-$6.45M
2025-03-31-$4.81M$0.00-$4.32M$0.00$0.00$4.92M
2024-12-31-$2.74M-$4.59M$5,000.00-$5,000.00$5.03M
2024-09-30$1.41M
2024-06-30$5.2M
2024-03-31-$15.02M-$1.58M$14,000.00-$14,000.00$2.73M
2023-12-31$1.05M$121,000.00-$70,000.00-$13,000.00
2023-09-30$1.75M
2023-06-30$808,000.00
2023-03-31$1.66M-$709,000.00-$10M$10.09M
2022-12-31-$2.7M-$1.32M$1.5M
2022-09-30-$2.44M
2022-06-30-$2.62M
2022-03-31-$2.71M-$1.64M$1.5M
2021-12-31-$2.16M-$1.65M$0.00$1.5M
2021-09-30-$1.96M
2021-06-30-$2.47M
2021-03-31-$2.09M-$2.63M$666,000.00$2.25M
2020-12-31-$2.45M-$1.62M$0.00$0.00$992,000.00
2020-09-30-$2.54M
2020-06-30-$2.69M
2020-03-31-$3.19M-$2.06M$4,000.00-$4,000.00$185,000.00
2019-12-31-$2.71M-$2.41M$295,000.00-$295,000.00$1.29M
2019-09-30-$3.22M
2019-06-30-$3.09M
2019-03-31-$3.13M-$2.62M$3,000.00-$3,000.00$4.5M
2018-12-31-$3.19M-$2.05M$0.00$3,000.00$0.00
2018-09-30-$2.15M
2018-06-30-$1.93M
2018-03-31-$235,000.00-$2.01M$1,000.00$2.41M$737,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$19.18M$100,000.00-$17.96M$59,000.00-$59,000.00$17.41M
2024-12-31-$11.14M$100,000.00-$17.14M$22,000.00-$22,000.00$13.21M
2023-12-31$5.27M-$2.48M-$504,000.00$10.07M
2022-12-31-$10.46M-$5.94M$6M
2021-12-31-$8.68M-$7.86M$666,000.00$7.25M
2020-12-31-$10.87M-$7.82M$20,000.00-$20,000.00$5.96M
2019-12-31-$12.15M-$10.16M$641,000.00-$361,000.00$6.27M
2018-12-31-$7.5M-$8M$21,000.00$1.33M$6M
2017-12-31-$6.58M-$6.29M$1,000.00$5,000.00$13.28M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.